UNCHF(UNCHF)
UNCHF
No analyst ratings available
No analyst price targets available for UNCHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.00T | $1.05T | $1.10T | $1.13T | $1.18T |
| Low | $980.23B | $1.02T | $1.07T | $1.10T | $1.14T |
| High | $1.02T | $1.12T | $1.15T | $1.18T | $1.23T |
| EBITDA Avg | $187.32B | $196.84B | $205.97B | $211.02B | $219.93B |
| Low | $183.41B | $190.41B | $200.42B | $205.34B | $214.01B |
| High | $191.49B | $209.30B | $214.89B | $220.16B | $229.45B |
| EBIT Avg | $139.62B | $146.72B | $153.52B | $157.29B | $163.93B |
| Low | $136.71B | $141.92B | $149.39B | $153.05B | $159.52B |
| High | $142.73B | $156.01B | $160.17B | $164.10B | $171.03B |
| Net Income Avg | $80.54B | $88.08B | $96.84B | $105.61B | $118.29B |
| Low | $77.73B | $85.00B | $93.45B | $101.91B | $114.15B |
| High | $85.08B | $93.04B | $102.29B | $111.55B | $124.95B |
| EPS Avg | $46.07 | $50.39 | $55.40 | $60.41 | $67.67 |
| Low | $44.46 | $48.62 | $53.46 | $58.30 | $65.30 |
| High | $48.67 | $53.22 | $58.52 | $63.81 | $71.47 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 8 / 1 | 12 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $245.73B | $273.41B |
| Low | $239.61B | $266.61B |
| High | $254.45B | $283.11B |
| EBITDA Avg | $45.98B | $51.16B |
| Low | $44.83B | $49.88B |
| High | $47.61B | $52.97B |
| EBIT Avg | $34.27B | $38.13B |
| Low | $33.42B | $37.18B |
| High | $35.49B | $39.48B |
| Net Income Avg | $17.53B | $23.24B |
| Low | $16.96B | $22.49B |
| High | $18.33B | $24.31B |
| EPS Avg | $10.11 | $13.41 |
| Low | $9.79 | $12.97 |
| High | $10.58 | $14.03 |
| Analysts (Rev / EPS) | 9 / 1 | 8 / 1 |